Living definition
What is Skylark Bio SKY-GJB2 Gene Therapy?
Synthetic Biology & Gene Editing Bio, Health & Neuro
- As of
- 2026-08-20
- Revision
- 2026-08-17.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Skylark Bio SKY-GJB2 Gene Therapy is an investigational gene therapy designed to deliver a functional copy of the GJB2 gene, which encodes the connexin 26 protein needed for normal inner-ear cell communication, to cells of the cochlea. It is intended for direct administration into the inner ear via a viral vector carrier, aiming to restore connexin 26 function in patients whose hearing loss stems from GJB2 mutations linked to congenital deafness.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-08-20, verified readiness is 10 (claimed 20, reported 16, gap 10) — Strong evidence strength; current signals suggest Track; not yet.
The readiness fact belongs to the canonical Readiness Verdict for Skylark Bio SKY-GJB2 Gene Therapy.
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-08-17.1
- Hash
- sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
- Approved
- 2026-08-17